ERBB2 mutations and association with molecular phenotype in urothelial carcinoma

被引：0
|
作者：
Machaalani, Marc
El Zarif, Talal
Stockhammer, Paul
Semaan, Karl
Eid, Marc
Chehade, Razane El Hajj
Nawfal, Rashad
Yekeduz, Emre
Nassar, Amin
Lee, Gwo-Shu Mary
Baca, Sylvan C.
Choueiri, Toni K.
Grant, Michael J.
Bellmunt, Joaquim
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT USA
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Canc Ctr, New Haven, CT USA
[5] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4590
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Functional characterization of ERBB2 mutations and response to targeted therapies
    Johnsen, Hannah
    Hanrahan, Aphrothiti
    Jones, Alexis
    Solit, David
    CLINICAL CANCER RESEARCH, 2016, 22
  • [42] Oncogenic and drug-sensitive ERBB2 mutations in glioblastoma
    Greulich, Heidi
    Chheda, Milan
    Chen, Tzu-Hsiu
    Tanaka, Kumiko
    Dutt, Amit
    Wong, Kwok-Kin
    Hahn, William
    Meyerson, Matthew
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [43] Discovery of somatic ERBB2 mutations in human gallbladder cancer
    Iyer, P.
    Gardi, N.
    Ranjan, M.
    Chandrani, P.
    Upadhyay, P.
    Ramadwar, M. R.
    Shrikhande, S. V.
    Dutt, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S55 - S55
  • [44] Lung adenocarcinoma harboring mutations in the ERBB2 kinase domain
    Sonobe, Makoto
    Manabe, Toshiaki
    Wada, Hiromi
    Tanaka, Fumihiro
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (03): : 351 - 356
  • [45] Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer
    Zito, Christina I.
    Riches, David
    Kolmakova, Julia
    Simons, Jan
    Egholm, Michael
    Stern, David F.
    GENES CHROMOSOMES & CANCER, 2008, 47 (07): : 633 - 638
  • [46] Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma
    Augustin, J. E.
    Soussan, P.
    Bass, A. J.
    ANNALS OF ONCOLOGY, 2022, 33 (11) : 1134 - 1148
  • [47] The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma
    Bożena Konopka
    Aneta Janiec-Jankowska
    Zygmunt Paszko
    Marian Goluda
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 114 - 121
  • [48] The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma
    Konopka, B
    Janiec-Jankowska, A
    Paszko, Z
    Goluda, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (02) : 114 - 121
  • [49] Molecular interactions of ERBB2 -: Implications for cancer therapy
    Vereb, G
    Nagy, P
    Zsebik, B
    Friedlander, E
    Isola, J
    Jovin, TM
    Park, JW
    Szöllosi, J
    CYTOMETRY PART A, 2004, 59A (01): : 93 - 93
  • [50] Clinical and molecular immune characterization of ERBB2 in glioma
    Mei, Jie
    Wang, Tiejun
    Xu, Rui
    Chen, Daozhen
    Zhang, Yan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 94
12345